↓ Skip to main content

Healthcare reform in the United States and China: pharmaceutical market implications

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#44 of 405)
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

blogs
1 blog
twitter
5 X users
facebook
1 Facebook page

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Healthcare reform in the United States and China: pharmaceutical market implications
Published in
Journal of Pharmaceutical Policy and Practice, July 2014
DOI 10.1186/2052-3211-7-9
Pubmed ID
Authors

Arthur Daemmrich, Ansuman Mohanty

Abstract

The United States and China are broadening health insurance coverage and increasing spending on pharmaceuticals, in contrast to other major economies that are reducing health spending and implementing a variety of drug price controls. This article analyzes the implications of health system reforms in the United States and China for national pharmaceutical markets. It follows a historical institutionalist approach that identifies path dependency in the design and operation of national health systems. On that basis, we estimate prescription sales for 2015 and 2020, analyze the sustainability of free-market pricing for drugs in the two countries, and assess future competitive dynamics in the pharmaceutical sector.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 65 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 23%
Student > Ph. D. Student 9 14%
Student > Master 8 12%
Student > Bachelor 8 12%
Student > Doctoral Student 6 9%
Other 8 12%
Unknown 12 18%
Readers by discipline Count As %
Medicine and Dentistry 15 23%
Social Sciences 10 15%
Economics, Econometrics and Finance 7 11%
Business, Management and Accounting 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Other 11 17%
Unknown 13 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2015.
All research outputs
#1,966,613
of 22,758,248 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#44
of 405 outputs
Outputs of similar age
#20,910
of 226,895 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 5 outputs
Altmetric has tracked 22,758,248 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 405 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,895 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them